Plasmakoncentrationen of ribavirin synes ikke at påvirkes af samtidig administration af reverse nukleotid transkriptasehæmmere (NRTIs).
However, due to high variability, the confidence intervals were quite wide. Plasma exposure of ribavirin did not appear to be affected by concomitant administration of nucleoside reverse transcriptase inhibitors (NRTIs).